Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple -Dose Safety, Pharmacokinetics, and Drug I-261025119
University of Arizona, Tucson, AZ, United States
Search grants from University of Arizona
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Pilot Study of Childhood Leukemia in Guatemala
A conditional allele to dissect Porcn-dependent Wnt signaling in vivo
Core - Long Term Follow-Up
Detection of Polypeptide Alterations During Hepatocarcinogenesis
Role of Cytokines in Allergic Disorders
Recently added grants:
Functional Effects of Ovarian Cancer Risk Variants
Improving the efficacy of mTOR inhibition
The role of NRF2 in reflux-induced esophageal adenocarcinomas
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
The Role of ATM in Suppression of Lymphomas
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025119-000
Application #
6688660
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85722
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple -Dose Safety, Pharmacokinetics, and Drug I-261025119
/ University of Arizona
NIH 2002
N01 CA
Phase I Single and Multiple -Dose Safety, Pharmacokinetics, and Drug I-261025119
/ University of Arizona
Comments
Be the first to comment on this grant